93 related articles for article (PubMed ID: 20393028)
1. ELISA measurement for urinary 3-hydroxyproline-containing peptides and its preliminary application to healthy persons and cancer patients.
Saito J; Imamura Y; Itoh J; Matsuyama S; Maruta A; Hayashi T; Sato A; Wada N; Kashiwazaki K; Inagaki Y; Watanabe T; Kitagawa Y; Okazaki I
Anticancer Res; 2010 Mar; 30(3):1007-14. PubMed ID: 20393028
[TBL] [Abstract][Full Text] [Related]
2. Endogenous urinary 3-hydroxyproline has 96% specificity and 44% sensitivity for cancer screening.
Okazaki I; Matsuyama S; Suzuki F; Maruyama K; Maruta A; Kubochi K; Yoshino K; Kobayashi Y; Abe O; Tsuchiya M
J Lab Clin Med; 1992 Dec; 120(6):908-20. PubMed ID: 1453112
[TBL] [Abstract][Full Text] [Related]
3. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
4. [Urine levels of polyamine in patients with or without cancer].
Tsunoda A
Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):816-25. PubMed ID: 3670267
[TBL] [Abstract][Full Text] [Related]
5. [Determination of urinary immunosuppressive acidic protein in cancer patients].
Hirayama T; Tamura K; Kikuchi S; Shibata Y; Kanno H; Sato Y; Ishida N; Kikuchi K
Gan No Rinsho; 1983 Sep; 29(11):1323-9. PubMed ID: 6685196
[TBL] [Abstract][Full Text] [Related]
6. [Effects of aging on urinary secretion of 3-hydroxyproline and its importance for cancer screening in the elderly with ROC analysis].
Bos AJ; Yuan P; Maruta A; Matsuyama S; Arai M; Okazaki I
Nihon Eiseigaku Zasshi; 1994 Oct; 49(4):797-806. PubMed ID: 7807707
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of urinary and serum cross-linked N-telopeptide of type I collagen (NTx) for diagnosis of bone metastasis in patients with lung cancer.
Tamiya M; Tokunaga S; Okada H; Suzuki H; Kobayashi M; Sasada S; Okamoto N; Morishita N; Matsuura Y; Miyamoto N; Hattori M; Taira K; Daga H; Takeda K; Hirashima T
Clin Lung Cancer; 2013 Jul; 14(4):364-9. PubMed ID: 23276824
[TBL] [Abstract][Full Text] [Related]
8. New marker of bone resorption: hydroxyproline-containing peptide. High-performance liquid chromatographic assay without hydrolysis as an alternative to hydroxyproline determination: a preliminary report.
Mazzi G; Fioravanzo F; Burti E
J Chromatogr B Biomed Appl; 1996 Apr; 678(2):165-72. PubMed ID: 8738018
[TBL] [Abstract][Full Text] [Related]
9. Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening.
Hardt PD; Toepler M; Ngoumou B; Rupp J; Kloer HU
Anticancer Res; 2003; 23(2A):855-7. PubMed ID: 12820313
[TBL] [Abstract][Full Text] [Related]
10. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
[TBL] [Abstract][Full Text] [Related]
11. Utility of slot-blot-ELISA as a new, fast, and sensitive immunoassay for detection of carcinoembryonic antigen in the urine samples of patients with various gastrointestinal malignancies.
El-Masry S; El-Sayed IH; Lotfy M; Mahmoud L; El-Naggar M
J Immunoassay Immunochem; 2007; 28(2):91-105. PubMed ID: 17424828
[TBL] [Abstract][Full Text] [Related]
12. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
[TBL] [Abstract][Full Text] [Related]
13. Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer.
Hutchinson LM; Chang EL; Becker CM; Ushiyama N; Behonick D; Shih MC; DeWolf WC; Gaston SM; Zetter BR
Clin Biochem; 2005 Jun; 38(6):558-71. PubMed ID: 15885237
[TBL] [Abstract][Full Text] [Related]
14. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
[TBL] [Abstract][Full Text] [Related]
15. Urinary markers of altered collagen metabolism in fibromyalgia patients.
Ribel-Madsen S; Christgau S; Gronemann ST; Bartels EM; Danneskiold-Samsøe B; Bliddal H
Scand J Rheumatol; 2007; 36(6):470-7. PubMed ID: 18092271
[TBL] [Abstract][Full Text] [Related]
16. 3-Hydroxyproline content of normal urine.
Adams E; Ramaswamy S; Lamon M
J Clin Invest; 1978 Jun; 61(6):1482-7. PubMed ID: 659611
[TBL] [Abstract][Full Text] [Related]
17. An office-based immunodiagnostic assay for detecting urinary nuclear matrix protein 52 in patients with bladder cancer.
Attallah AM; Sakr HA; Ismail H; Abdel-Hady el-SK; El-Dosoky I
BJU Int; 2005 Aug; 96(3):334-9. PubMed ID: 16042726
[TBL] [Abstract][Full Text] [Related]
18. [Significance of a simple assay of urine telomerase activity for the detection of bladder cancer].
Iwabuchi I; Mori K; Yamamoto H; Hatakeyama S; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Suzuki T; Ohyama C
Hinyokika Kiyo; 2010 Oct; 56(10):551-7. PubMed ID: 21063158
[TBL] [Abstract][Full Text] [Related]
19. Dinitrophenyl derivatization of imino acids, spectral characteristics and HPLC analysis: application in urinary peptide-derived hydroxyproline and proline assay.
Badadani M; Babu SV; Shetty KT
Ann Clin Biochem; 2007 Mar; 44(Pt 2):164-72. PubMed ID: 17362582
[TBL] [Abstract][Full Text] [Related]
20. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
